Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies

Vaccine

Volumn 28, Issue 39, 2010, Pages 6445-6454

  van Drunen Littel van den Hurk, Sylvia ^a,b   Lawman, Zoe ^a   Wilson, Don ^a   Luxembourg, Alain ^c   Ellefsen, Barry ^c   van den Hurk, Jan V ^a   Hannaman, Drew ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Ichor Medical Systems Inc   (United States)

Author keywords

BVDV E2 protein; DNA vaccine; Electroporation; Newborn calves

Indexed keywords

BOVINE DIARRHEA VIRUS DNA VACCINE; DNA VACCINE; MATERNAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CALF (BOVINE); CATTLE DISEASE; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; ELECTROPORATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INTERMETHOD COMPARISON; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 2, BOVINE VIRAL; ELECTROPORATION; IMMUNITY, HUMORAL; IMMUNITY, MATERNALLY-ACQUIRED; NEUTRALIZATION TESTS; VACCINES, DNA; VIRAL VACCINES;

EID: 77956399432     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.045     Document Type: Article

References (59)

1. Ridpath J.F. Bovine viral diarrhea virus: global status. Vet Clin North Am Food Anim Pract 2010, 26(March (1)):105-121. [table of contents].
2. Kelling C.L. Evolution of bovine viral diarrhea virus vaccines. Vet Clin North Am Food Anim Pract 2004, 20(March (1)):115-129.
3. Pellerin C., van den Hurk J., Lecomte J., Tussen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 1994, 203(September (2)):260-268.
4. Ridpath J.F., Bolin S.R., Dubovi E.J. Segregation of bovine viral diarrhea virus into genotypes. Virology 1994, 205(November (1)):66-74.
5. Ridpath J.F., Neill J.D., Frey M., Landgraf J.G. Phylogenetic, antigenic and clinical characterization of type 2 BVDV from North America. Vet Microbiol 2000, 77(November (1-2)):145-155.
6. Hamers C., Dehan P., Couvreur B., Letellier C., Kerkhofs P., Pastoret P.P. Diversity among bovine pestiviruses. Vet J 2001, 161(March (2)):112-122.
7. Bruschke C.J., Weerdmeester K., Van Oirschot J.T., Van Rijn P.A. Distribution of bovine virus diarrhoea virus in tissues and white blood cells of cattle during acute infection. Vet Microbiol 1998, 64(November (1)):23-32.
8. Bolin S.R., McClurkin A.W., Coria M.F. Effects of bovine viral diarrhea virus on the percentages and absolute numbers of circulating B and T lymphocytes in cattle. Am J Vet Res 1985, 46(April (4)):884-886.
9. Moenning V. Pestiviruses: a review. Vet Microbiol 1990, 23(June (1-4)):35-54.
10. Rush D.M., Thurmond M.C., Munoz-Zanzi C.A., Hietala S.K. Descriptive epidemiology of postnatal bovine viral diarrhea virus infection in intensively managed dairy heifers. J Am Vet Med Assoc 2001, 219(November (10)):1426-1431.
11. Bak A., Callesen H., Meyling A., Greve T. Calves born after embryo transfer from donors persistently infected with BVD virus. Vet Rec 1992, 131(July (2)):37.
12. Houe H. Age distribution of animals persistently infected with bovine virus diarrhea virus in twenty-two Danish dairy herds. Can J Vet Res 1992, 56(July (3)):194-198.
13. Houe H., Baker J.C., Maes R.K., Wuryastuti H., Wasito R., Ruegg P.L., et al. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody-positive cattle among herds with different infection and vaccination status. J Vet Diagn Invest 1995, 7(July (3)):321-326.
14. Bolin S.R., Ridpath J.F. Frequency of association of noncytopathic bovine viral diarrhea virus with bovine neutrophils and mononuclear leukocytes before and after treatment with trypsin. Am J Vet Res 1990, 51(November (11)):1847-1851.
15. Collett M.S., Larson R., Belzer S.K., Retzel E. Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus. Virology 1988, 165(July (1)):200-208.
16. Collett M.S., Wiskerchen M., Welniak E., Belzer S.K. Bovine viral diarrhea virus genomic organization. Arch Virol Suppl 1991, 3:19-27.
17. Gil L.H., Ansari I.H., Vassilev V., Liang D., Lai V.C., Zhong W., et al. The amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism. J Virol 2006, 80(January (2)):900-911.
18. Rumenapf T., Unger G., Strauss J.H., Thiel H.J. Processing of the envelope glycoproteins of pestiviruses. J Virol 1993, 67(June (6)):3288-3294.
19. Weiland E., Stark R., Haas B., Rumenapf T., Meyers G., Thiel H.J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol 1990, 64(August (8)):3563-3569.
20. Donis R.O. Molecular biology of bovine viral diarrhea virus and its interactions with the host. Vet Clin North Am Food Anim Pract 1995, 11(November (3)):393-423.
21. Bolin S.R. Immunogens of bovine viral diarrhea virus. Vet Microbiol 1993, 37(November (3-4)):263-271.
22. Brock K.V. Strategies for the control and prevention of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 2004, 20(March (1)):171-180.
23. Ellis J., West K., Cortese V., Konoby C., Weigel D. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 2001, 219(August (3)):351-356.
24. Endsley J.J., Roth J.A., Ridpath J., Neill J. Maternal antibody blocks humoral but not T cell responses to BVDV. Biologicals 2003, 31(June (2)):123-125.
25. Endsley J.J., Ridpath J.F., Neill J.D., Sandbulte M.R., Roth J.A. Induction of T lymphocytes specific for bovine viral diarrhea virus in calves with maternal antibody. Viral Immunol 2004, 17(Spring (1)):13-23.
26. Siegrist C.A., Lambert P.H. Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines. Springer Semin Immunopathol 1997, 19(2):233-243.
27. Van Drunen Littel-van den Hurk S., Braun R.P., Lewis P.J., Karvonen B.C., Babiuk L.A., Griebel P.J. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol 1999, 12(1):67-77.
28. Hassett D.E., Zhang J., Slifka M., Whitton J.L. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J Virol 2000, 74(6):2620-2627.
29. Gerdts V., Babiuk L.A., van Drunen Littel-van den H., Griebel P.J. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 2000, 6(August (8)):929-932.
30. van Drunen Littel-van den Hurk S. Novel methods for the non-invasive administration of DNA therapeutics and vaccines. Curr Drug Deliv 2006, 3(1):3-15.
31. Luxembourg A., Evans C.F., Hannaman D. Electroporation based DNA immunization: translation to the clinic. Exp Opin Biol Ther 2007, 7(11):1647-1664.
32. Babiuk S., Baca-Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002, 20(September (27-28)):3399-3408.
33. Otten G., Schaefer M., Doe B., Liu H., Srivastava I., zur Megede J., et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 2004, 22(June (19)):2489-2493.
34. Scheerlinck J.P., Karlis J., Tjelle T.E., Presidente P.J., Mathiesen I., Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 2004, 22(April (13-14)):1820-1825.
35. Luxembourg A., Hannaman D., Nolan E., Ellefsen B., Nakamura G., Chau L., et al. Potentiation of an anthrax DNA vaccine with electroporation. Vaccine 2008, (40):5216-5222.
36. Babiuk S., Tsang C., van Drunen Littel-van den Hurk S., Babiuk L.A., Griebel P.J. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry 2007, 70(May (2)):269-274.
37. Tsang C., Babiuk S., van Drunen Littel-van den Hurk S., Babiuk L.A., Griebel P. A single DNA immunization in combination with electroporation prolongs the primary immune response and the duration of immune memory. Vaccine 2007, 25:5485-5494.
38. van Drunen Littel-van den Hurk S., Luxembourg A., Ellefsen B., Wilson D., Ubach A., Hannaman D., et al. Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle. Vaccine 2008, 26(October (43)):5503-5509.
39. Liang R., Babiuk L.A., van Drunen Littel-van den Hurk S. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation. Vaccine 2007, 25(August (32)):5994-6006.
40. Liang R., van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., et al. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine 2005, 23(November (45)):5252-5262.
41. Liang R., van den Hurk J.V., Landi A., Lawman Z., Deregt D., Townsend H., et al. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J Gen Virol 2008, 89(February (Pt 2)):453-466.
42. Nakamura Y., Gojobori T., Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 2000, 28(January (1)):292.
43. Pontarollo R.A., Babiuk L.A., Hecker R., Van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 2002, 83(December (Pt 12)):2973-2981.
44. Liang R., van den Hurk J.V., Babiuk L.A., van Drunen Littel-van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. J Gen Virol 2006, 87(October (Pt 10)):2971-2982.
45. Raggo C., Habermehl M., Babiuk L.A., Griebel P. The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. J Gen Virol 2000, 81(Pt 11):2665-2673.
46. Ridpath J.F. BVDV genotypes and biotypes: practical implications for diagnosis and control. Biologicals 2003, 31(June (2)):127-131.
47. Ridpath J.F. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs. Prev Vet Med 2005, 72(November (1-2)):17-30. [discussion 215-9].
48. Marchant A., Goetghebuer T., Ota M.O., Wolfe I., Ceesay S.J., De Groote D., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999, 163(August (4)):2249-2255.
49. Mascart F., Verscheure V., Malfroot A., Hainaut M., Pierard D., Temerman S., et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol 2003, 170(February (3)):1504-1509.
50. Mbawuike I.N., Wells J., Byrd R., Cron S.G., Glezen W.P., Piedra P.A. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis 2001, 183(March (5)):687-696.
51. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(July (24)):3406-3412.
52. Zimmerman A.D., Boots R.E., Valli J.L., Chase C.C. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine. J Am Vet Med Assoc 2006, 228(June (11)):1757-1761.
53. Kelling C.L., Hunsaker B.D., Steffen D.J., Topliff C.L., Eskridge K.M. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves. Am J Vet Res 2007, 68(July (7)):788-796.
54. Makoschey B., Janssen M.G., Vrijenhoek M.P., Korsten J.H., Marel P. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine 2001, 19(April (23-24)):3261-3268.
55. Ficken M.D., Ellsworth M.A., Tucker C.M., Cortese V.S. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation. J Am Vet Med Assoc 2006, 228(May (10)):1559-1564.
56. Luxembourg A., Hannaman D., Wills K., Bernard R., Tennant B., Menne S., et al. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis antigens. Vaccine 2008, 26(32):4025-4033.
57. Livingston B.D., Little S.F., Luxembourg A., Ellefsen B., Hannaman D. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 2009, (November).
58. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 2007, 81(May (10)):5257-5269.
59. Van Donkersgoed J., McCartney D., Van Drunen Littel-van den Hurk S. Efficacy of an experimental BHV 1 subunit gIV vaccine in beef calves challenged with BHV 1 in aerosol. Can J Vet Res 1996, 60(1):55-58.